Prostate Cancer Trends in Developing Countries

Authors

  • Aleyamma Mathew Regional Cancer Center, Trivandrum 695011, India
  • Francis V. James Regional Cancer Center, Trivandrum 695011, India

DOI:

https://doi.org/10.17140/CSMMOJ-3-e003

Abstract

Prostate cancer is the commonest cancer in USA and most European Countries and is the 2nd commonest cancer among males globally. An estimated 1.1 million men worldwide were diagnosed with prostate cancer in 2012, accounting for 15% of the cancers diagnosed in men. Incidence of this disease varies more than 25-fold worldwide; the rates are highest in Australia/New Zealand and Northern America (ASR 111.6 and 97.2 per 100,000 respectively), and in Western and Northern Europe, because the practice of prostate specific antigen (PSA) testing and subsequent biopsy has become widespread in those regions.

References

Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5): E359-E386. doi: 10.1002/ijc.29210

Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Cancer Epidemiol Biomarkers Prev. 2010; 19(8): 1893-1907. doi: 10.1158/1055-9965.EPI-10-0437

Gomez SL, Noone AM, Lichtensztajn DY, et al. Cancer Incidence Trends Among Asian American Populations in the United States,1990–2008. J Natl Cancer Inst. 2013; 105(15): 1096-1110. doi: 10.1093/jnci/djt157

Jain S, Saxena S, Kumar A. Epidemiology of prostate cancer in India. Meta Gene. 2014; 2: 596-605. doi: 10.1016/j. mgene.2014.07.007

Pienta KJ, Esper PS. Risk Factors for Prostate Cancer. Ann Intern Med. 1993; 118(10): 793-803. Cancer Stud Mol Med Open J Page e2

Downloads

Published

2016-09-14

How to Cite

Aleyamma Mathew, & Francis V. James. (2016). Prostate Cancer Trends in Developing Countries. Cancer Studies and Molecular Medicine , 3(1), e1-e2. https://doi.org/10.17140/CSMMOJ-3-e003

Issue

Vol. 3 No. 1 (2016): Volume 3 Issue 1 2016

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.